A carregar...

Dendritic cell-based immunotherapy in ovarian cancer

Worldwide, 80% of patients with ovarian cancer die of the disease. New treatments for this aggressive disease are therefore being intensively searched. Although dendritic cell-based vaccines against gynecological malignancies are in their infancy, this immunotherapeutic approach holds much promise....

ver descrição completa

Detalhes bibliográficos
Autores principales: Coosemans, An, Vergote, Ignace, Van Gool, Stefaan W
Formato: Online Artigo Texto
Idioma:English
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913669/
https://www.ncbi.nlm.nih.gov/pubmed/24501688
http://dx.doi.org/10.4161/onci.27059